Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SwampMan完成签到,获得积分10
刚刚
聪慧石头发布了新的文献求助10
刚刚
jzt12138发布了新的文献求助10
1秒前
优雅若蕊发布了新的文献求助10
1秒前
Junly发布了新的文献求助10
1秒前
1秒前
Jasper应助难过的谷芹采纳,获得10
1秒前
wanci应助科研通管家采纳,获得10
2秒前
乐乐应助科研通管家采纳,获得10
2秒前
null应助科研通管家采纳,获得10
2秒前
俊逸忻应助科研通管家采纳,获得10
2秒前
CodeCraft应助沈世尧采纳,获得10
2秒前
MIZU应助科研通管家采纳,获得10
2秒前
科研通AI2S应助科研通管家采纳,获得10
2秒前
无极微光应助超级的冷松采纳,获得20
2秒前
搜集达人应助科研通管家采纳,获得10
2秒前
小马甲应助科研通管家采纳,获得10
3秒前
CodeCraft应助科研通管家采纳,获得10
3秒前
吃瓜少女应助科研通管家采纳,获得10
3秒前
赘婿应助科研通管家采纳,获得10
3秒前
英俊的铭应助科研通管家采纳,获得30
3秒前
3秒前
852应助科研通管家采纳,获得10
3秒前
汉堡包应助科研通管家采纳,获得10
4秒前
wanci应助科研通管家采纳,获得10
4秒前
null应助科研通管家采纳,获得10
4秒前
乐乐应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
null应助科研通管家采纳,获得10
4秒前
4秒前
SciGPT应助科研通管家采纳,获得10
4秒前
俊逸忻应助科研通管家采纳,获得10
4秒前
4秒前
科研通AI6.1应助11采纳,获得10
4秒前
MIZU应助科研通管家采纳,获得10
4秒前
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
搜集达人应助科研通管家采纳,获得10
4秒前
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
Ägyptische Geschichte der 21.–30. Dynastie 1100
„Semitische Wissenschaften“? 1100
Real World Research, 5th Edition 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5735420
求助须知:如何正确求助?哪些是违规求助? 5360561
关于积分的说明 15329871
捐赠科研通 4879609
什么是DOI,文献DOI怎么找? 2622093
邀请新用户注册赠送积分活动 1571250
关于科研通互助平台的介绍 1528108